Search Results

Below are the search engine results of your query.

Showing 1-10 of 16 results for "R142b"

Vertrel™ Specialty Fluids

Vertrel™ specialty fluids act as fluorinated solvents, cleaners, and more.

The Chemours Company Reports Fourth Quarter and Full Year 2018 Results

Full Year 2018 Highlights Net Sales of $6.6 billion, up 7% Net Income of $995 million, up 33%, with EPS of $5.45, up 39% Adjusted Net Income of $1.0 billion, up 42%, with Adjusted EPS of $5.67, up 48% Adjusted EBITDA of $1.7 billion, up 22% Returned over $790 million to shareholders through share repurchases and dividends Fourth Quarter 2018 Highlights Net Sales of $1.5 billion Net Income of $142 ...

The Chemours Company Reports First Quarter 2017 Results; Significant Earnings Improvements in All Segments

First Quarter 2017 Highlights Net Sales of $1.4 billion , up 11%, including impacts from divestitures Net Income of $150 million , up $99 million with EPS of $0.79 , up $0.51 per diluted share Adjusted EBITDA of $285 million , up 123%, demonstrating margin improvement across all segments Adjusted Net Income of $142 million , up $131 million with Adjusted EPS of $0.75 , up $0.69 per diluted share A...

Chemours Recognized at 2015 Polyurethane’s Technical Conference for Best Low Global Warming Potential Blowing Agent Technical Presentation

The Chemours Company Reports Fourth Quarter and Full Year 2019 Results

Full Year 2019 Results In-line with Updated Guidance Full Year 2019 Results Net Sales of $5.5 billion Net Income of $(52) million with EPS of $(0.32) Adjusted Net Income of $419 million with Adjusted EPS of $2.51 Adjusted EBITDA of $1.02 billion Free Cash Flow of $169 million Returned $486 million to shareholders through share repurchases and dividends Fourth Quarter 2019 Results Net Sales of $1.4...

The Chemours Company Reports Second Quarter 2019 Results

Committed to Core Growth Strategy Despite Near Term Headwinds Second Quarter 2019 Highlights Net Sales of $1.4 billion Net Income of $96 million, with diluted EPS of $0.57 Adjusted Net Income of $120 million, with diluted Adjusted EPS of $0.72 Adjusted EBITDA of $283 million Returned $108 million to shareholders through share repurchases and dividends Other Highlights Completed the acquisition of ...

The Chemours Company Reports Second Quarter 2018 Results, Double Digit Growth Across All Key Financial Metrics, EPS up 82 Percent with Adjusted EPS up 99 Percent

S econd Quarter 2018 Highlights Net Sales of $1.8 billion, up 14% Net Income of $281 million, up 75% with EPS of $1.53, up 82% Adjusted Net Income of $314 million, up 91% with Adjusted EPS of $1.71, up 99% Adjusted EBITDA of $497 million, up 38% Board authorized new $750 million share repurchase program and increased dividend to $0.25 per share Expect full-year 2018 Adjusted EBITDA in top end of r...

Fayetteville Works

We are committed to taking a leadership role in environmental stewardship.

The Chemours Company Reports Strong Second Quarter Results and Increases Full-Year 2017 Outlook

Second Quarter 2017 Highlights Net Sales of $1.6 billion , up 15% Net Income of $161 million , up $179 million with EPS of $0.84 , up $0.94 per diluted share Adjusted EBITDA of $361 million , up $174 million , driven by strong year-over-year volume and price improvement in Titanium Technologies and Fluoroproducts Adjusted Net Income of $166 million , up $117 million with Adjusted EPS of $0.87 , up...

The Chemours Company Reports First Quarter 2019 Results

Continuing to Aggressively Return Capital to Shareholders First Quarter 2019 Highlights Net Sales of $1.4 billion Net Income of $94 million, with EPS of $0.55 Adjusted Net Income of $109 million, with Adjusted EPS of $0.63 Adjusted EBITDA of $262 million Returned $261 million to shareholders through share repurchases The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leadi...